A blood test is expected to help patients switch to more effective prostate cancer treatments earlier than is currently possible A test that detects prostate cancer cells in the bloodstream could improve the treatment of men with advanced disease and speed up development of new therapies, experts have said. Measuring numbers of circulating tumour cells can identify which men are benefiting least from a drug treatment in as little as 12 weeks, a study found.